ACELLYTRON THERAPEUTICS
LIVE

Serial Number

79389188

Owner

Wuxi Biologics (Shanghai) Co., Ltd.

Attorney

Michael T. Smith

Filing Date

Nov 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ACELLYTRON THERAPEUTICS Trademark

Serial Number: 79389188 • Registration: 8081479

ACELLYTRON THERAPEUTICS is a trademark filed by Wuxi Biologics (Shanghai) Co., Ltd. on November 28, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Wuxi Biologics (Shanghai) Co., Ltd. (11 trademarks)

Building 2, No. 31 Yiwei Road,

Entity Type: 03

Trademark Details

Filing Date

November 28, 2023

Registration Date

December 30, 2025

Published for Opposition

November 11, 2025

Goods & Services

Chemico-pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer; biochemical medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer; drugs for medical purposes, namely, medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological agent, namely, biological preparations for treating cancer; pharmaceutical preparations for the prevention and treatment of cancer; living cells for medical use; medical cell inhibitor for inhibiting the growth of cancer cells; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; pharmaceutical preparations, namely, tumor suppressor; cells for medical use; dietetic infusions, sugar, foods, and beverages adapted for medical use; biological preparations for veterinary purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer

Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance

Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing; sponsorship search; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies

Research and development of new products for others; technological research in the field of chemical and biological medicaments; chemical analysis; biochemical research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research; computer programming in the field of medical aspects

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 23, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 6, 2026 FICS
FINAL DISPOSITION PROCESSED
Jul 6, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 30, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 30, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 10, 2025 TROA
REFUSAL PROCESSED BY IB
Aug 1, 2025 RFNT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 26, 2025 OPNX
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 15, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jul 15, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 15, 2025 RFCR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 7, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 7, 2025 OPNR
NON-FINAL ACTION WRITTEN
Jun 27, 2024 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jun 27, 2024 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 27, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 26, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 10, 2024 REPR